Portal de Periódicos da CAPES

SGLT2 Inhibitors in Patients with Advanced Heart Failure Awaiting Heart Transplant: Preliminary Results from The SGLT2i-HT Study

2024; Elsevier BV; Volume: 43; Issue: 4 Linguagem: Inglês

10.1016/j.healun.2024.02.727

1557-3117

Guglielmo Gallone, Stefano Pidello, Emanuele Bertarelli, Andrea Tedeschi, D Maione, Giulio Cacioli, Nicola Pradegan, Chiara Tessari, Concetta Di Nora, Alessandro Verde, Enrico Perna, Claudia Raineri, Matteo Marro, Erika Simonato, F Breviario, F. Cavallier, Cristiano Amarelli, Annalisa Turco, Igor Vendramin, Gino Gerosa, Laura Scelsi, Paola Lilla Della Monica, Gianfranco Sinagra, Andrea Garascia, Marco Merlo, Mauro Rinaldi, Gaetano Maria De Ferrari, Massimo Boffini,

Potassium and Related Disorders

Purpose: Sodium-glucose co-transporter 2 inhibitors (SGLT2-i) reduce mortality in patients with heart failure (HF). However, their efficacy in patients with advanced HF listed for heart transplant (HT) is unknown.